Stem Cell Research: Moving Forward The Role of Government 1 Presentation given on November 29, 2012From:thereveriepangViews:1 0ratingsTime:09:01More inEducation Visit link: Stem Cell Research: Moving Forward … Continue reading →

Advancing Stem Cell Research... Dr. Bernard Thbaud explains the potential of using cord blood derived stem cells to treat BPD (chronic lung disease) one day at the CHEO Research Institute.From:CHEOvideosViews:0 0ratingsTime:03:51More inScience Technology View original post here: Advancing Stem Cell Research... - Video … Continue reading →

"Ask the Experts - Living with ALS" Seminar at Cedars-Sinai Medical Center On Saturday, November 17, 2012, world-renowned researchers involved in the study of ALS participated in a this special event, "Ask the Experts -- Living with ALS" at Cedars-Sinai Medical Center in Los Angeles, California. The event, hosted by The ALS Association Golden West Chapter, offered people with ALS and their loved ones an opportunity to ask their questions directly to scientists and clinicians. Speakers include Catherine Lomen-Hoerth, MD, Ph.D., Director, The ALS Center at UCSF, who will discuss multidisciplinary care and ALS along with The ALS Association's Chief Scientist, Lucie Bruijn, Ph.D., who will present an overview of ALS research. Following these discussions, Robert H. Baloh, MD, Ph.D., Director, Cedars-Sinai ALS Center, Don W. Cleveland, Ph.D, Department Chair, UCSD, and Clive Svendsen, Ph.D., Director, Cedars-Sinai RMI and Chair of the California ALS Research Network will speak about topics such as clinical trials, genetics, and stem cell research. To find out more, please visit: http://www.alsagoldenwest.org or httpFrom:Calabasas3Views:7 0ratingsTime:02:57:25More inEducation Continue reading here: "Ask the Experts - Living with ALS" Seminar at Cedars-Sinai Medical Center - Video … Continue reading →

NEW YORK, NY and PETACH TIKVAH, ISRAEL--(Marketwire - Dec 4, 2012) - Sai Rosen of http://www.InvestorStemCell.com (Stem Cell Media, LLC) recently sat down with Dr. Adrian Harel, Chief Executive Officer for Brainstorm Cell Therapeutics Inc. ( OTCQB : BCLI ).Brainstorm Cell Therapeutics Inc. is a biotechnology company developing autologous stem cell therapies for highly debilitating neurodegenerative disorders, such as Amyotrophic Lateral Sclerosis (ALS) (Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson's disease (PD) and Spinal Cord Injury. These diseases have limited treatment options and as such represent unmet medical needs. Dr. Harel has over 30 years' experience in international business development, marketing, clinical development, fund raising and building strategic partnerships. In January 2011, he came to Brainstorm and leveraged all his experience to transform the company from a struggling pre-clinical biotech to the world's leader in clinical stage neurodegenerative treatment for ALS.The company is nearing submission of an ALS Phase II, to be conducted at the renowned Massachusetts General Hospital (MGH). During his interview, Dr. Harel shared the following information: Why are you interested in neurodegenerative disorders? Dr. Harel: "I became fascinated in this area of research while working at Proneuron Biotechnologies.We had created the 'world center' for paralysis.I had … Continue reading →

TORONTO, ONTARIO--(Marketwire - Dec. 4, 2012) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS) ("SCT" or the "Company") a life sciences development company of stem cell-related therapeutics, today announced a reminder that a Special Meeting of Shareholders will be held in the Offices of McCarthy Ttrault LLP, Toronto Dominion Bank Tower, 66 Wellington Street West, 53rd Floor, J.J. Robinette Boardroom, Toronto, ON M5K 1E6, on Thursday, December 20, 2012, at 10:00 a.m. Eastern Time. The Special Meeting will consider resolutions set forth in the Management Information Circular dated November 22, 2012, accessible on SEDAR at http://www.sedar.com. Interested shareholders, unable to attend the meeting in person, can listen to the proceedings live via conference call. Stem Cell Therapeutics has provided a corporate update for its shareholders, which is available on the Investors page of the Company's website: http://www.stemcellthera.com. Mr. David Allan, Executive Chairman of Stem Cell Therapeutics will also host a question and answer session following the Special Meeting. Conference call participants wishing to ask a question will be instructed by the operator on how to do so at this time. Details to listen live: About Stem Cell Therapeutics Stem Cell Therapeutics Corp. (TSX VENTURE:SSS) is a Canadian commercialization receptor company in … Continue reading →

CARLSBAD, CA--(Marketwire - Dec 4, 2012) - International Stem Cell Corporation ( OTCQB : ISCO ) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based biotechnology company focused on therapeutic and research products, today announced that Executive Vice President, Dr. Simon Craw will attend and present at the Fifth Annual LD Micro Conference on December 6, 2012 at the Luxe Hotel Sunset Boulevard in Los Angeles, California. LD Micro Conference Presentation DetailsDate: Thursday, December 6, 2012 Time: 12:00 pm PST Location: Luxe Hotel Sunset Boulevard, Los Angeles, California Conference details: http://www.ldmicro.com Please contact the conference organizers if you have an interest in attending the conference or if you would like to arrange a meeting with International Stem Cell Corporation's management team. To register for the event, please call 408-457-1042 or e-mail Chris@ldmicro.com.You may also contact Mark McPartland with MZ Group via email markmcp@mzgroup.us or phone 1-212-301-7130 to arrange a meeting with management at the conference. The LD Micro Conference is a two-day conference organized by LD Micro, an internet-based newsletter that provides self-directed investors information on selected public companies that in the opinion of LD Micro have great investment potential. More than 200 institutions focused on small and micro-cap stocks are expected … Continue reading →